385 related articles for article (PubMed ID: 24178906)
1. Increased rate of lung function decline in Australian adolescents with cystic fibrosis.
Welsh L; Robertson CF; Ranganathan SC
Pediatr Pulmonol; 2014 Sep; 49(9):873-7. PubMed ID: 24178906
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis.
Schneiderman JE; Wilkes DL; Atenafu EG; Nguyen T; Wells GD; Alarie N; Tullis E; Lands LC; Coates AL; Corey M; Ratjen F
Eur Respir J; 2014 Mar; 43(3):817-23. PubMed ID: 24176992
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
[TBL] [Abstract][Full Text] [Related]
4. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function.
Terliesner N; Vogel M; Steighardt A; Gausche R; Henn C; Hentschel J; Kapellen T; Klamt S; Gebhardt J; Kiess W; Prenzel F
J Pediatr Endocrinol Metab; 2017 Aug; 30(8):815-821. PubMed ID: 28245190
[TBL] [Abstract][Full Text] [Related]
5. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.
Steinkamp G; Wiedemann B
Thorax; 2002 Jul; 57(7):596-601. PubMed ID: 12096202
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.
Zemel BS; Jawad AF; FitzSimmons S; Stallings VA
J Pediatr; 2000 Sep; 137(3):374-80. PubMed ID: 10969263
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
Kerem E; Viviani L; Zolin A; MacNeill S; Hatziagorou E; Ellemunter H; Drevinek P; Gulmans V; Krivec U; Olesen H;
Eur Respir J; 2014 Jan; 43(1):125-33. PubMed ID: 23598952
[TBL] [Abstract][Full Text] [Related]
8. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
9. Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis.
Amadori A; Antonelli A; Balteri I; Schreiber A; Bugiani M; De Rose V
Respir Med; 2009 Mar; 103(3):407-13. PubMed ID: 19027279
[TBL] [Abstract][Full Text] [Related]
10. Lung function comparison between two decades in cystic fibrosis children: A single centre study.
Tridello G; Volpi S; Assael BM; Meneghelli I; Passiu M; Circelli M
Pediatr Pulmonol; 2015 Dec; 50(12):1237-43. PubMed ID: 26422228
[TBL] [Abstract][Full Text] [Related]
11. Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function.
Morgan WJ; Wagener JS; Yegin A; Pasta DJ; Millar SJ; Konstan MW; ;
J Pediatr; 2013 Oct; 163(4):1152-7.e2. PubMed ID: 23810128
[TBL] [Abstract][Full Text] [Related]
12. Lung function decline from adolescence to young adulthood in cystic fibrosis.
Vandenbranden SL; McMullen A; Schechter MS; Pasta DJ; Michaelis RL; Konstan MW; Wagener JS; Morgan WJ; McColley SA;
Pediatr Pulmonol; 2012 Feb; 47(2):135-43. PubMed ID: 22241571
[TBL] [Abstract][Full Text] [Related]
13. Decline in lung function does not predict future decline in lung function in cystic fibrosis patients.
Rosenfeld M; VanDevanter DR; Ren CL; Elkin EP; Pasta DJ; Konstan MW; Morgan WJ;
Pediatr Pulmonol; 2015 Sep; 50(9):856-62. PubMed ID: 26086901
[TBL] [Abstract][Full Text] [Related]
14. Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use.
McPhail GL; Acton JD; Fenchel MC; Amin RS; Seid M
J Pediatr; 2008 Dec; 153(6):752-7. PubMed ID: 18760423
[TBL] [Abstract][Full Text] [Related]
15. Bronchiectases at early chest computed tomography in children with cystic fibrosis are associated with increased risk of subsequent pulmonary exacerbations and chronic pseudomonas infection.
Bortoluzzi CF; Volpi S; D'Orazio C; Tiddens HA; Loeve M; Tridello G; Assael BM
J Cyst Fibros; 2014 Sep; 13(5):564-71. PubMed ID: 24726420
[TBL] [Abstract][Full Text] [Related]
16. Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis.
Ren CL; Konstan MW; Yegin A; Rasouliyan L; Trzaskoma B; Morgan WJ; Regelmann W;
J Cyst Fibros; 2012 Jul; 11(4):293-9. PubMed ID: 22445849
[TBL] [Abstract][Full Text] [Related]
17. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
[TBL] [Abstract][Full Text] [Related]
18. Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes.
Sims EJ; Green MW; Mehta A
Diabetes Care; 2005 Jul; 28(7):1581-7. PubMed ID: 15983304
[TBL] [Abstract][Full Text] [Related]
19. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral.
Rosenbluth DB; Wilson K; Ferkol T; Schuster DP
Chest; 2004 Aug; 126(2):412-9. PubMed ID: 15302726
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
Konstan MW; Morgan WJ; Butler SM; Pasta DJ; Craib ML; Silva SJ; Stokes DC; Wohl ME; Wagener JS; Regelmann WE; Johnson CA;
J Pediatr; 2007 Aug; 151(2):134-9, 139.e1. PubMed ID: 17643762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
